SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
for Locally Advanced /Metastatic Solid Tumors
Sites in Houston, Dallas +5 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT07857616·Phase 1·Not Yet Recruiting·Listed Oct 5, 2026
Non-small cell lung cancer (NSCLC) Clinical Trials in Houston, TX
As of October 2026, 111 paid clinical trials are recruiting for Non-small cell lung cancer (NSCLC) in Houston, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Houston
Filter results
Filter results
Newly added in Houston
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
112 clinical trials for Non-small cell lung cancer (NSCLC)
·Clear filters· Email me when a new non-small cell lung cancer (nsclc) trial opens in Houston, TX.
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for Non-small Cell Lung Cancer (NSCLC)
Drug: Durvalumab
Sites in Houston, Austin +35 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07361497·Phase 3·Recruiting·Listed Jan 2026
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for Advanced Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Houston, Humble +224 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07222566·Phase 3·Recruiting·Listed Oct 2025
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Sites in Houston, Galveston +39 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07361510·Phase 3·Recruiting·Listed Jan 2026
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for Advanced/Metastatic Non-Small Cell Lung Cancer
Drug: PF-08634404
Sites in Houston, Sugar Land +53 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT07227298·Phase 1, Phase 2·Recruiting·Listed Nov 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Houston, Spring +117 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Houston, Sugar Land +88 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Houston, Webster +84 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for Non-small Cell Lung Cancer
Drug: Zongertinib
Sites in Houston, Abilene +25 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
for Non-Small Cell Lung Cancer
Drug: sigvotatug vedotin
Sites in Houston, Sugar Land +81 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT06758401·Phase 3·Recruiting·Listed Jan 2025
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
for NSCLC (Non-small Cell Lung Cancer)
Drug: daraxonrasib
Sites in Houston, The Woodlands +43 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06881784·Phase 3·Recruiting·Listed Mar 2025
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
Drug: Divarasib
Sites in Houston, Kingwood +61 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
Drug: Intismeran autogene
Sites in Houston, Tyler +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for Non-Small Cell Lung Cancer
Sites in Houston, San Antonio +24 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07100080·Phase 2, Phase 3·Recruiting·Listed Aug 2025
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
Sites in Houston, Austin +27 more locations
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for Mesothelioma
Drug: MRTX1719
Sites in Houston, Tyler +20 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05245500·Phase 1·Recruiting·Listed Feb 2022
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for Non-small Cell Lung Cancer
Drug: Relatlimab
Sites in Houston, Tyler +39 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06561386·Phase 3·Recruiting·Listed Aug 2024
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Houston, San Antonio +23 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06586515·Phase 1·Recruiting·Listed Sep 2024
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Sites in Houston +22 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
Sites in Houston +23 more locations
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for Non-Small Cell Lung Cancer
Drug: Ivonescimab
Sites in Houston, Webster +95 more locations
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for Carcinoma, Non-Small-Cell Lung
Sites in Houston, San Antonio +23 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT05208762·Phase 1·Recruiting·Listed Jan 2022
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for Cancer, Metastatic
Sites in Houston, Temple +65 more locations
Sponsor: Massive Bio, Inc.
Sex: All·Age: All ages
Code: NCT03452774·Recruiting·Listed Mar 2018
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for ER+, HER 2- Breast Cancer
Sites in Houston, Austin +9 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18 - 99
Code: NCT07540572·Phase 1·Recruiting·Listed Apr 2026
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for Esophageal Squamous Cell Carcinoma
Sites in Houston, Austin +13 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Non Small Cell Lung Cancer
Drug: REGN7075
Sites in Houston, Galveston +15 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07154290·Phase 2·Recruiting·Listed Sep 2025
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for Non-Small Cell Lung Cancer (NSCLC)
Drug: Sotorasib
Sites in Houston, Irving +24 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT05920356·Phase 3·Recruiting·Listed Jun 2023
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
for Non-Small Cell Lung Cancer
Drug: Divarasib
Sites in Houston +10 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT05789082·Phase 1, Phase 2·Recruiting·Listed Mar 2023
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for Metastatic Solid Tumor
Drug: LY4052031
Sites in Houston, San Antonio +20 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06465069·Phase 1·Recruiting·Listed Jun 2024
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
for Non-small Cell Lung Cancer
Sites in Houston +15 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06422143·Phase 3·Recruiting·Listed May 2024
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for Non-small Cell Lung Cancer
Drug: Calderasib
Sites in Houston +11 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06345729·Phase 3·Recruiting·Listed Apr 2024
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer
Sites in Houston, Kingwood +23 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06899126·Phase 3·Recruiting·Listed Mar 2025
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for Non-Small Cell Lung Cancer
Drug: Livmoniplimab
Sites in Houston, San Antonio +10 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06236438·Phase 2, Phase 3·Recruiting·Listed Feb 2024
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Sites in Houston +16 more locations
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All·Age: 18+
Code: NCT06667908·Phase 2·Recruiting·Listed Oct 2024
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for Non-Small Cell Lung Cancer (NSCLC)
Drug: daraxonrasib
Sites in Houston, San Antonio +18 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Houston +15 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
for Advanced Solid Tumor
Sites in Houston, Austin +8 more locations
Sponsor: Aulos Bioscience, Inc.
Sex: All·Age: 18+
Code: NCT05267626·Phase 1, Phase 2·Recruiting·Listed Mar 2022
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer
Sites in Houston, Waco +21 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
for Advanced Solid Tumor
Sites in Houston +11 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06172478·Phase 2·Recruiting·Listed Dec 2023
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Houston +12 more locations
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07020221·Phase 1, Phase 2·Recruiting·Listed Jun 2025
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for Non Small Cell Lung Cancer
Sites in Houston +21 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023
Top Research Study Locations in Houston
Researchers run research studies in Houston, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MD Anderson Cancer Center | Colorectal Cancer, Ovarian Cancer, Breast Cancer | 409 |
| M D Anderson Cancer Center | Hematopoietic and Lymphoid Cell Neoplasm, Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | 244 |
| Baylor College of Medicine | Epilepsy, Breast Cancer, Heart Failure | 190 |
| The University of Texas Health Science Center at Houston | Cluster Headache, HIV Infections, Systemic Sclerosis | 187 |
| The University of Texas MD Anderson Cancer Center | Advanced Solid Tumor, Breast Cancer, Colorectal Cancer | 134 |
| Houston Methodist Hospital | Acute Respiratory Distress Syndrome, ARDS, ARDS (Acute Respiratory Distress Syndrome) | 126 |
| Texas Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, WHO Grade III Glioma | 108 |
| The University of Texas M. D. Anderson Cancer Center | Cancer, Prostate Cancer, Advanced Cancer | 84 |
| UT MD Anderson Cancer Center | Metastatic Malignant Solid Neoplasm, Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm | 83 |
| University of Texas MD Anderson Cancer Center | Non-small Cell Lung Cancer, Advanced Solid Tumors, Breast Cancer | 82 |
| Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 56 |
| MD Anderson | Myelodysplastic Syndromes, Myelofibrosis, Acute Myeloid Leukemia | 39 |
| UT MD Anderson | Breast Cancer, Cancer, Head and Neck Cancer | 36 |
| Houston Methodist | Heart Failure, Cardiovascular Diseases, Heart Valve Diseases | 35 |
| Michael E. DeBakey VA Medical Center, Houston, TX | Spinal Cord Injury, Metastatic Prostate Cancer, Adult Growth Hormone Deficiency | 30 |
| University of Texas Health Science Center at Houston | Infant, Small for Gestational Age, Infant, Low Birth Weight, Infant, Newborn | 29 |
| Ben Taub General Hospital | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 26 |
| GSK Investigational Site | Chickenpox, HIV Infections, Pulmonary Disease, Chronic Obstructive | 21 |
| Houston Methodist Research Institute | AAA, AAA - Abdominal Aortic Aneurysm, Acute Hypercapnic Respiratory Failure | 21 |
| The University of Texas M.D. Anderson Cancer Center | Advanced Breast Cancer, Breast Cancer, Metastatic Breast Cancer | 17 |
| UTHealth Houston | Acute Suicidal Depression (ASD), Charcot-Marie-Tooth Disease Type 2D, Emergency Department Visits | 16 |
| Michael E. DeBakey VA Medical Center | Gulf War Syndrome, Adult Growth Hormone Deficiency, Alzheimer Disease | 15 |
| Houston Methodist West Hospital | Anatomic Stage II Breast Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, AL Amyloidosis | 15 |
| Memorial Hermann Texas Medical Center | Acute Kidney Injury, Ischemic Stroke, Ovarian Carcinoma | 14 |
| UT Health Houston | Breast Cancer, 4H Syndrome, ADLD | 14 |
Active & Upcoming Studies in Houston (2026)
Recruiting trials in Houston grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (1,183 active studies)
- A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML) · Phase 1, Phase 2 · M.D. Anderson Cancer Center
- Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial · Phase 2 · National Cancer Institute (NCI)
Neurology & pain (138 active studies)
- Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction in Chronic Stroke · EARLY_Phase 1 · University of Houston
- Prospective Randomized Study of TPS + CBT VS TPS Alone: Readmission, Opioid Use, and Chronic Pain · M.D. Anderson Cancer Center
Cardiovascular (106 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation · Oslo University Hospital
Diabetes & metabolic (100 active studies)
- Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer · Phase 2 · The Methodist Hospital Research Institute
- A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity · Phase 3 · Novo Nordisk A/S
Mental health & behavior (80 active studies)
- ACT for Veterans With IBD and Mental Health Challenges · VA Office of Research and Development
- Pilot Randomized Trial of BA-GSH in VA PC-MHI · VA Office of Research and Development
Pediatric (44 active studies)
- Food is Medicine in Survivorship: Examining the Feasibility and Impact of a Scalable Food Delivery and Culinary Medicine Program (FoodiiS) Among Pediatric Cancer Survivors and Their Families · M.D. Anderson Cancer Center
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
HIV / STI (33 active studies)
- Improving HIV Prevention and Substance Use Post-Sexual Assault Services · The University of Texas Health Science Center, Houston
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (31 active studies)
Eye & vision (24 active studies)
- A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). · Phase 3 · 4D Molecular Therapeutics
- Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg · Ocular Aesthetics, LLC dba Ocular Clinical Trials
Common conditions studied in Houston
- Breast Cancer (74 active studies)
- Acute Myeloid Leukemia (52 active studies)
- Advanced Solid Tumor (51 active studies)
- Colorectal Cancer (49 active studies)
- Ovarian Cancer (48 active studies)
- Prostate Cancer (45 active studies)
Leading research sponsors in Houston
- M.D. Anderson Cancer Center
- The University of Texas Health Science Center, Houston
- Baylor College of Medicine
- AstraZeneca
- The Methodist Hospital Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Houston?
There are approximately 3,037 recruiting clinical trials in Houston, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Houston pay participants?
Most recruiting trials in Houston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Houston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Houston?
The most common conditions under active study in Houston include Breast Cancer (74), Acute Myeloid Leukemia (52), Advanced Solid Tumor (51), Colorectal Cancer (49), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Houston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Houston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Houston?
Recruiting research sites in Houston include MD Anderson Cancer Center, M D Anderson Cancer Center, Baylor College of Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Houston right now?
The largest active categories in Houston are Cancer & tumors (1,183), Neurology & pain (138), Cardiovascular (106). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Texas
Dallas, TX(1,565)San Antonio, TX(994)Austin, TX(694)Fort Worth, TX(328)El Paso, TX(181)Plano, TX(168)Tyler, TX(161)Sugar Land, TX(133)Irving, TX(115)The Woodlands, TX(108)Lubbock, TX(106)Bellaire, TX(103)Amarillo, TX(82)Richardson, TX(82)Galveston, TX(80)McAllen, TX(73)McKinney, TX(72)Corpus Christi, TX(71)Temple, TX(70)Arlington, TX(66)DeSoto, TX(64)Mesquite, TX(63)Webster, TX(63)Tomball, TX(54)Waco, TX(53)Katy, TX(50)Abilene, TX(49)Round Rock, TX(49)Cypress, TX(47)Beaumont, TX(46)Kingwood, TX(43)Frisco, TX(41)Conroe, TX(40)Edinburg, TX(37)League City, TX(37)Baytown, TX(36)Southlake, TX(36)Denton, TX(35)Lewisville, TX(35)Humble, TX(33)Denison, TX(31)Harlingen, TX(31)Mansfield, TX(31)Weslaco, TX(31)Brownsville, TX(29)Wichita Falls, TX(28)Longview, TX(27)Georgetown, TX(26)Shavano Park, TX(24)Garland, TX(23)Sherman, TX(23)Allen, TX(22)Carrollton, TX(22)Richmond, TX(22)College Station, TX(20)Bedford, TX(19)Flower Mound, TX(19)Fort Sam Houston, TX(18)Pearland, TX(18)Cedar Park, TX(17)